The lack of adequate activation of T lymphocytes in the tumor microenvironment may be because anti-tumor responses of T lymphocytes are inhibited by soluble factors such as TGF-β and IL-10 that are secreted by glioma cells (12). This evidence concerns the gene IL10 and glioma.